Evaluation of β-cyclodextrin-modified gemini surfactant-based delivery systems in melanoma models

Novel drug delivery systems are developed to improve the biological behavior of poorly soluble drugs and to improve therapeutic outcomes. In melanoma therapy, the goal is efficient drug delivery and mitigation of drug resistance. Melphalan (Mel), a currently used therapeutic agent for melanoma, requ...

Descripción completa

Detalles Bibliográficos
Autores principales: Michel, Deborah, Mohammed-Saeid, Waleed, Getson, Heather, Roy, Caitlin, Poorghorban, Masoomeh, Chitanda, Jackson M, Verrall, Ronald, Badea, Ildiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161338/
https://www.ncbi.nlm.nih.gov/pubmed/28003746
http://dx.doi.org/10.2147/IJN.S121156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161338/
https://www.ncbi.nlm.nih.gov/pubmed/28003746
http://dx.doi.org/10.2147/IJN.S121156

Ejemplares similares